本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

9.87
-0.3200-3.14%
盤前9.900.0300+0.30%04:00 EDT
成交量:340.57萬
成交額:3,418.63萬
市值:21.61億
市盈率:-6.98
高:10.32
開:10.21
低:9.81
收:10.19
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:1.47
換手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.15
市盈率(LYR):-6.95

資料載入中...

2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities